 |
 |
 |
|
David Hable - Former CEO Codman J&J
Julie Olson, PhD - Former VP R&D
Licensing, Pfizer
Bill Wardell, MD - Former Chief
Medical Officer, Covance
Tom Garvey, MD - Former Supervisory
Medical Officer Cardio-Renal Drug Eval, FDA
Mary Southam, PhD - Former VP Technology
Assessment Alza (J&J)
David Armistead, PhD - Former Head of Chem.,
Vertex, VP Research, Amgen
Bill Rohr, MD - Former Senior Vice
President R&D Zimmer
Russell Garlick, PhD - Former VP
R&D, Perkin Elmer Life Sciences
Barry Eisenstein, PhD- SVP Scientific
Affairs, Cubist; VP R&D, Eli Lilly
Bob Karr, PhD - Former SVP Strategy
Pfizer
Jeff Leighton, PhD - Former Vice
President of Pharmacology, GSK
Michael Tarnow, JD - Former CEO
Merck Canada
Barry Hafkin, MD - Former Head of Antibacterials, Pharmacia; CMO, Affinium
Merrill Egorin, MD - Co-Director, Drug Discovery Prog., UPitt Cancer Institute
Gordon Douglas, MD - Former President of Merck Vaccines
Robert Kamen, PhD - Former President, Abbott/BASF BioResearch
William Schwieterman, MD - Former Center for Biologicals, FDA
Michael Ellwein - Former Chief Development Officer, Medtronic
Omar Amirana - Former VP Business Development St. Jude Medical
Frederic J Huser - Former President of Novartis, North America OTC Division
Jon St. Germain - VP of R&D, Cardiovascular Division, St. Jude Medical
|
| |
